(EI) 313 ([M + H]+, 3%). A portion of this material (556 mg,
1.78 mmol) was mixed with N-hydroxysuccinimide (440 mg,
3.83 mmol) and dicyclohexylcarbodiimide (770 mg, 3.76 mmo◦ l)
in tetrahydrofuran (20 mL) under anhydrous conditions at 0 C
for 3 h then at room temperature overnight. Following filtra-
tion of the mixture, the filtrate was concentrated on a rotary
evaporator and chromatographed on a silica column eluted with
toluene–ethyl acetate (4 : 1 v/v). Fractions at Rf = 0.59 were
combined and evaporated to yield a white solid which was
recrystallized from hexane + ethyl acetate to yield succinimidyl
11-iodoundecanoate (387 mg, 53% yield, mp 84 ◦C; nmax/cm-1
1725 (CO); dH (400 MHz, CDCl3, Me4Si) 3.16 (2 H, t, J 7,
ICH2CH2), 2.81 (4 H, s, COCH2CH2CO), 2.57 (2 H, t, J 7,
CH2CH2COO), 1.79 (2 H, quintet, J 7, ICH2CH2), 1.71 (2 H,
quintet, J 7, CH2CH2CH2COO), 1.41–1.22 (12 H, m, ICH2CH2
(CH2)6CH2CH2COO); dC (400 MHz, CDCl3, Me4Si) 7.7, 25.0,
26.0, 28.9, 29.1, 29.4, 29.6, 29.7, 30.9, 31.3, 34.0, 169.1, 169.6; m/z
0.17 mmol) and 1,2-dichloroethane (1.6 mL) was refluxed under
nitrogen for 21 h. The yellow residue formed upon evaporation of
the solvent was extracted with dichloromethane (1 mL) and the ex-
tract chromatographed on silica gel eluted with dichloromethane–
acetonitrile (3 : 1 v/v). The fractions having Rf = 0.19 were pooled
and evaporated to give compound 3 as a yellow solid in low yield
(15.9 mg, 10.7%, mp 164–165 ◦C; nmax/cm-1 1815, 1779, 1733 (CO);
dH (400 MHz, CDCl3, Me4Si) 8.78 (2 H, d, J 9, 2 ¥ NCCHCH),
8.71 (2 H, d, J 9, 2 ¥ CCCHCH), 8.49 (2 H, dd, J 9, 7, 2 ¥
NCCHCHCH), 8.06 (2 H, d, J 8, 2 ¥ CF3CCHCH), 7.98 (2 H,
dd, J 9, 7, 2 ¥ CCCHCHCH), 7.12 (1 H, t, J 8, CF3CCHCHCH),
5.60 (2 H, t, J 8, NCH2CH2), 2.76 (4 H, s, COCH2CH2CO), 2.51
(2 H, t, J 7, CH2CH2COO), 2.29–2.18 (2 H, m), 1.84–1.69 (4 H, m)
and 1.51–1.26 (10 H, m) (NCH2(CH2)8CH2COO). dC (400 MHz,
CDCl3, Me4Si) 24.9, 26.0, 26.9, 29.0, 29.3, 29.4, 29.5, 29.6, 30.1,
31.3, 53.3, 119.8, 124.3, 125.7, 126.0, 128.5, 129.0, 130.0, 132.4,
140.6, 141.7, 144.9, 161.8, 169.1, 169.7; dF (400 MHz, CDCl3)
-78.4 (CF3SO3 ), -59.8 (CF3); m/z (ES+) 717.2390 (M+ – CF3SO3 )
+
-
-
(CI) 427 (M + NH4 , 15%), 301 (15), 225 (16), 149 (30) 132 (100).
This material (188 mg, 0.460 mmol) was mixed with silver triflu-
oromethanesulfonate (214 mg, 0.836 mmol) in benzene (1.5 mL)
under anhydrous conditions for 18 h at room temperature and the
mixture chromatographed on a short (2 g) silica column eluted
with dichloromethane. Fractions at Rf = 0.48 were combined
and evaporated to yield a white gum consisting of succinimidyl
11-(trifluoromethanesulfonyloxy)undecanoate (133 mg, 67%);
(100%) C37H35F6N2O6 requires 717.2394), 519 (17), 505 (8), 491 (9).
Synthesis of 2-(4-dimethylaminophenylazo)-N-[2-(2-iodoacetyl-
amino)ethyl]benzamide (Compound 6). 2-[4-(Dimethylamino)-
phenylazo]benzoic acid (1.251 g, 4.65 mmol) in THF (30 mL)
was cooled to 0 ◦C and dicyclohexylcarbodiimide (1.103 g,
5.3 mmol) was added, followed by N-hydroxysuccinimide (0.568 g,
4.94 mmol). The mixture was stirred at 0 ◦C for 2 h, thence
overnight at room temperature. The mixture was filtered and the
filtrate evaporated to dryness to give a red solid which was recrys-
tallised from acetone–diethyl ether and dried under vacuum to give
succinimidyl 2-[4-(dimethylamino)phenylazo]benzoate (0.849 g,
50%, mp 124–126 ◦C; FAB-MS m/z 361 [(M + H)+, 23%], 252 [17],
133 [100]). A portion of this (74 mg, 0.20 mmol) in dioxane (2 mL)
was mixed with t-butyl N-(2-aminoethyl)carbamate (99 mg,
0.63 mmol) in methanol (1 mL). The mixture was shaken at room
temperature in the dark for 4 h. Tlc (toluene–EtOAc 1 : 1) showed
that all the starting material (Rf = 0.85, violet) was converted
into a new component (Rf = 0.60, orange). Combined fractions
from chromatography on a silica gel column eluted with toluene–
EtOAc 1 : 1 yielded N-[2-(t-butoxycarbonylamino)ethyl]-2-[4-
(dimethylamino)phenylazo]benzamide as an orange solid (75 mg,
n
max/cm-1 1819, 1787, 1725 (CO); dH (400 MHz, CDCl3, Me4Si)
4.44 (2 H, t, J 7, SOCH2CH2), 2.74 (4 H, s, COCH2CH2CO),
2.51 (2 H, t, J 7, CH2CH2COO), 1.73 (2 H, quintet, J 7,
SOCH2CH2), 1.65 (2 H, quintet, J 7, CH2CH2CH2COO), 1.37–
1.17 (12 H, m, SOCH2CH2(CH2)6CH2CH2COO); dC (400 MHz,
CDCl3, Me4Si) 24.9, 25.4, 26.0, 29.1, 29.2, 29.3, 29.4, 29.5, 29.6,
31.3, 78.1, 119.0, 169.0, 169.6; dF (400 MHz, CDCl3) -74.8. A
portion of the above product (57 mg, 0.13 mmol) was mixed
with 2,6-dinitrophenyl acridine-9-carboxylate (53 mg, 0.13 mmol)
in 1,2-dichloroethane (2 mL) and refluxed under nitrogen for
20 h. The solvent was evaporated and the residue dissolved in
dichloromethane and chromatographed on a small silica column
(0.5 g) eluted with dichloromethane followed by dichloromethane–
acetonitrile (3 : 1 v/v). Fractions having Rf = 0.17 were pooled
and evaporated to yield compound 2 in low yield (15.8 mg, 14%)
as a yellow oil. nmax/cm-1 1812, 1778, 1735 (CO); dH (400 MHz,
CDCl3, Me4Si) 8.71–8.60 (4 H, m, 2 ¥ NCCHCH, 2 ¥ CCCHCH),
8.41 (2 H, dd, J 8, 7, 2 ¥ NCCHCHCH), 8.34 (2 H, d, J 8, 2 ¥
NO2CCHCH), 7.92 (2 H, dd, J 9, 7, 2 ¥ CCCHCHCH), 7.78
(1 H, t, J 8, NO2CCHCHCH), 5.48 (2 H, t, J 8, NCH2CH2),
2.69 (4 H, s, COCH2CH2CO), 2.45 (2 H, t, J 7, CH2CH2COO),
2.08 (2 H, m), 1.68–1.53 (4 H, m) and 1.35–1.10 (10 H, m)
(NCH2(CH2)8CH2COO). dC (400 MHz, CDCl3, Me4Si) 24.9,
26.0, 26.9, 29.0, 29.2, 29.4, 29.5, 29.6, 30.1, 31.3, 53.1, 119.6,
124.1, 128.9, 129.7, 130.2, 131.1, 136.6, 140.7, 141.6, 143.9, 144.8,
◦
91%, mp 131–134 C; FAB-MS m/z 434.2 [(M + Na)+, (6%),
412 [(M + H)+, 50%], 252 (82), 133 (100). A portion of this
material (70 mg, 0.17 mmol) in dioxane (2 mL) was treated
with concentrated hydrochloric acid (0.6 ml). The orange solution
turned to violet. The mixture was stirred at room temperature for
15 min and then evaporated to dryness. The residue was washed
with dioxane (2 ¥ 3 mL) and diethyl ether (3 mL) and was then
dissolved in MeOH (4 mL). Aqueous saturated sodium bicar-
bonate solution (2 mL) was added followed by dichloromethane
(20 mL) and then water (20 mL). The organic layer was isolated,
dried over anhydrous magnesium sulfate and evaporated to give
N-(2-aminoethyl)-2-[4-(dimethylamino)phenylazo]benzamide as
a red solid (42 mg, 79%), mp 119–124 ◦C; FAB-MS m/z
312 [(M + H)+, 13%), 252 (31), 133 (100). To this material
(60 mg, 0.19 mmol) in dichloromethane (5 mL) was added
triethylamine (20 mg, 0.20 mmol). The mixture was cooled to
-
161.1, 169.1, 169.7; m/z (ES+) 671.2352 (M+ – CF3SO3 ) (100%)
C35H35N4O10 requires 671.2348), 519 (15), 505 (23), 491 (42), 361
(77), 246 (44).
Synthesis of 9-(2,6-bis(trifluoromethyl)phenoxycarbonyl)-10-
(10-succinimidyloxycarbonyldecyl)acridinium trifluoromethanesul-
fonate (Compound 3).
A
mixture of succinimidyl 11-
0
◦C and iodoacetyl chloride (40 mg, 0.20 mmol) was added.
(trifluoromethanesulfonyloxy)undecanoate (75 mg, 0.17 mmol),
2,6-bis(trifluoromethyl)phenylacridinium-9-carboxylate (75 mg,
After 5 min at 0 ◦C, tlc (CH3Cl–MeOH, 4 : 1) showed that most
of the starting material (Rf = 0.4) was converted into a new
392 | Org. Biomol. Chem., 2009, 7, 386–394
This journal is
The Royal Society of Chemistry 2009
©